Hormone Therapy
Menopause Treatment: Options, Evidence, and Safety
Medically reviewed by HealthRX.com Medical Team · Last reviewed
What are the symptoms of menopause?
Menopause is the permanent end of periods, on average around age 51, and perimenopause is the transition leading up to it. Common symptoms fall into four groups: hot flashes and night sweats, disturbed sleep, mood changes, and vaginal and urinary symptoms.
- Vasomotor: hot flashes and night sweats, the most characteristic symptom.
- Sleep: insomnia, often driven by night sweats.
- Mood: irritability, low mood and anxiety.
- Genitourinary: vaginal dryness, discomfort and urinary symptoms.
What is the most effective treatment?
Menopause hormone therapy (also called HRT) is the most effective treatment for hot flashes and night sweats and for vaginal symptoms, and it prevents bone loss. Non-hormonal options exist for women who cannot or prefer not to use hormones.
The Menopause Society states plainly that hormone therapy is the most effective treatment for vasomotor symptoms and prevents fracture. Non-hormonal options for hot flashes include certain SSRIs and SNRIs, gabapentin, and the newer agent fezolinetant. [1]
What did the Women's Health Initiative really show?
The 2002 WHI headlines caused a lasting overcorrection. The breast cancer signal came from estrogen combined with a synthetic progestin, not from estrogen alone. The absolute risks were small, and the average participant was in her 60s, not a woman starting therapy near menopause.
- Estrogen plus progestin modestly raised breast cancer risk; estrogen alone did not, and trended lower. [2][3]
- Absolute risk was small, on the order of a few extra cases per 10,000 women per year. [2]
- WHI used oral conjugated estrogen and oral progestin, not modern transdermal estradiol. [2]
- The findings do not represent a symptomatic 50-year-old starting therapy near menopause. [4]
Who is a good candidate, and when should therapy start?
Benefits favor starting hormone therapy under age 60 or within 10 years of menopause, often called the timing hypothesis. In that window the benefit-risk balance is favorable for healthy women. Starting more than 10 years out or after 60 carries greater absolute risk.
Hormone therapy is generally avoided by women with a history of breast cancer, estrogen-dependent cancer, unexplained bleeding, blood clots, recent stroke or heart attack, or liver disease. Therapy is individualized, and there is no fixed stop age. [1][4]
How does Menopause Treatment compare with other peptides?
| Hormone therapy | Non-hormonal options | |
|---|---|---|
| Hot flash relief | Most effective | Helpful for some |
| Bone protection | Yes | Not the main aim |
| Examples | Estradiol plus progesterone | SSRIs, SNRIs, gabapentin, fezolinetant |
| Best for | Under 60 or within 10 years | When hormones are not suitable |
Frequently asked questions
Is hormone therapy safe?
For most healthy women under 60 or within 10 years of their last period, the benefits for hot flashes and bone protection generally outweigh the risks. Safety depends on your age, health history, the type used and the dose, so individual review matters.
Does hormone therapy cause breast cancer?
The risk is smaller and more nuanced than headlines suggest. Estrogen combined with a synthetic progestin modestly raised risk in the WHI; estrogen alone did not and trended lower. For most women the added absolute risk is small.
When should I start hormone therapy?
Benefits favor starting under age 60 or within 10 years of menopause. In that window the balance is favorable for healthy women. Starting much later carries greater absolute risk, so timing is part of the decision.
Do I need progesterone?
If you still have your uterus, yes. Estrogen alone raises the risk of uterine cancer, and progesterone protects the lining. If you have had a hysterectomy, you generally do not need progesterone and can use estrogen alone.
How long can I stay on hormone therapy?
There is no fixed stop date or mandatory age limit. The Menopause Society recommends individualizing duration based on your symptoms, risks and preferences, with periodic review. Decisions to continue or stop are made with your clinician.
Citations
- The Menopause Society (NAMS). The 2022 hormone therapy position statement. Menopause. 2022;29(7):767-794.
- Rossouw JE, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women (WHI). JAMA. 2002;288(3):321-333.
- Anderson GL, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy (WHI). JAMA. 2004;291(14):1701-1712.
- Rossouw JE, et al. Postmenopausal hormone therapy and cardiovascular disease by age and years since menopause. JAMA. 2007;297(13):1465-1477.
This guide is educational and is not a substitute for individualized medical advice. Menopause Treatment is prescription-only and requires evaluation by a licensed provider.